A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.
A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.
Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Scientific publications authored or co-authored by PARI experts, highlighting advancements and key findings in aerosol science and inhaled drug delivery.
A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.
Objective Evaluation of Adherence to Inhaled Liposomal Cyclosporin Therapy for Lung Transplant Patients in a Clinical Trial.
Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.
New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.
The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.